Skip to main navigation Skip to search Skip to main content

A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: A report of the children's cancer group

  • Mitchell S. Cairo
  • , Mark D. Krailo
  • , Joel A. Weinthal
  • , Rita Secola
  • , Sharon Bergeron
  • , Carmella Van De Ven
  • , Bruce R. Blazar
  • , Leslie Garrison
  • , Gregory H. Reaman

Research output: Contribution to journal › Article › peer-review

12   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors: A report of the children's cancer group'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology